Low prevalence of anti-hepatitis E virus IgG antibodies in Tepehuanos in Mexico
| Autor: | Verónica Dayali Gutierrez-Martinez, Cosme Alvarado-Esquivel, Antonio Sifuentes-Alvarez, Eda Guadalupe Ramírez-Valles |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
Rural Population Multivariate analysis Epidemiology Sus scrofa Specialties of internal medicine medicine.disease_cause Hepatitis E virus Raw Foods Risk Factors Seroepidemiologic Studies Prevalence Aged 80 and over education.field_of_study biology Goats General Medicine Middle Aged Hepatitis E Milk RC581-951 Pasteurization Female Antibody Adult medicine.medical_specialty Turkeys Meat Adolescent Case–control study Population Young Adult Age Distribution Internal medicine medicine Seroprevalence Animals Humans Hepatitis Antibodies Sex Distribution education Columbidae Indigenous Peoples Mexico Aged Sheep Hepatology business.industry Drinking Water Case-control study Tepehuanos Diet Case-Control Studies Immunoglobulin G biology.protein Rural area business |
| Zdroj: | Annals of Hepatology, Vol 19, Iss 2, Pp 186-189 (2020) |
| ISSN: | 1665-2681 |
| Popis: | Introduction and objective: The epidemiology of infection with hepatitis E virus (HEV) in Tepehuanos (a Mexican ethnic group living in rural areas) is largely unknown. This study aimed to determine the seroprevalence of and risk factors associated with HEV infection in Tepehuanos in Durango, Mexico, and to compare this seroprevalence with that in non-Tepehuanos. Materials and methods: Through a case–control seroprevalence study, we studied 146 Tepehuanos and 146 age- and gender-matched control subjects of the general population from rural settings. The frequency of anti-HEV IgG antibodies was determined using an enzyme-linked immunoassay. Bivariate and multivariate analyses were used to assess the association between seropositivity and socio-demographic, clinical and behavioral characteristics of the Tepehuanos. Results: IgG antibodies against HEV were found in 5 (3.4%; 95% CI: 1.1–7.8) of 146 Tepehuanos and in 46 (31.5%; 95% CI: 24.1–39.7) of 146 control subjects (OR = 0.01; 95% CI: 0.0007–0.20; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|